Telsey Advisory Group reiterated their outperform rating on shares of Bath & Body Works (NYSE:BBWI - Free Report) in a report issued on Thursday morning,Benzinga reports. They currently have a $43.00 price target on the stock.
Other equities research analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft boosted their target price on Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Morgan Stanley dropped their target price on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a report on Thursday, November 21st. Barclays boosted their target price on Bath & Body Works from $28.00 to $34.00 and gave the stock an "underweight" rating in a report on Tuesday, November 26th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. raised Bath & Body Works from a "neutral" rating to an "overweight" rating and upped their price target for the company from $41.00 to $47.00 in a report on Tuesday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $43.63.
Check Out Our Latest Report on BBWI
Bath & Body Works Stock Performance
Shares of BBWI traded down $1.84 during mid-day trading on Thursday, reaching $38.51. 5,441,380 shares of the company's stock traded hands, compared to its average volume of 3,304,652. The business's 50-day moving average price is $37.70 and its 200-day moving average price is $33.86. The stock has a market capitalization of $8.34 billion, a P/E ratio of 9.39, a price-to-earnings-growth ratio of 0.95 and a beta of 1.83. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.58 billion. During the same quarter in the previous year, the company posted $0.48 earnings per share. The business's revenue for the quarter was up 3.1% compared to the same quarter last year. Equities research analysts anticipate that Bath & Body Works will post 3.26 EPS for the current year.
Bath & Body Works Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.08%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works's dividend payout ratio is currently 19.51%.
Hedge Funds Weigh In On Bath & Body Works
Institutional investors and hedge funds have recently modified their holdings of the stock. Wellington Management Group LLP purchased a new position in shares of Bath & Body Works during the 3rd quarter valued at $8,129,000. Forest Avenue Capital Management LP grew its holdings in shares of Bath & Body Works by 19.1% during the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company's stock valued at $46,851,000 after acquiring an additional 235,173 shares in the last quarter. Anthracite Investment Company Inc. purchased a new position in shares of Bath & Body Works during the 3rd quarter valued at $2,921,000. Principal Financial Group Inc. grew its holdings in shares of Bath & Body Works by 328.7% during the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company's stock valued at $34,153,000 after acquiring an additional 820,379 shares in the last quarter. Finally, iA Global Asset Management Inc. boosted its holdings in Bath & Body Works by 1,078.2% in the third quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company's stock worth $1,575,000 after purchasing an additional 45,144 shares in the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.
Bath & Body Works Company Profile
(
Get Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.